Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma. The safety and scientific validity of this study ... Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Paclitaxel. ... Open-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via ... In this open-label, dose-escalating, Phase IIa trial, subjects with locally advanced pancreatic adenocarcinoma will receive ...
Mesothelioma Glioblastoma Renal Cell Carcinoma Non Small Cell Lung Cancer Melanoma Pancreatic Ductal Adenocarcinoma Gastric ... Adenocarcinoma. Astrocytoma. Glioma. Neoplasms, Neuroepithelial. Head and Neck Neoplasms. Adenoma. Neoplasms, Mesothelial. ...
Adenocarcinoma. Breast Neoplasms. Neoplasms by Site. Breast Diseases. Skin Diseases. Urologic Neoplasms. Urogenital Neoplasms. ... Triple Negative Breast Cancer Renal Cell Cancer High Grade Ovarian Serous Adenocarcinoma Squamous Cell Carcinoma of the Head ...
Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Futibatinib. Antineoplastic ...
Has persistent, recurrent, or metastatic squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix ...